Gateway Investment Advisers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.7M | Buy |
8,920
+2,066
| +30% | +$1.16M | 0.05% | 178 |
|
|
2026
Q1 | $3.85M | Sell |
6,854
-5,441
| -44% | -$3.49M | 0.04% | 188 |
|
|
2025
Q4 | $8.32M | Buy |
12,295
+1,851
| +18% | +$1.26M | 0.08% | 150 |
|
|
2025
Q3 | $6.67M | Sell |
10,444
-2,595
| -20% | -$1.58M | 0.06% | 167 |
|
|
2025
Q2 | $6.99M | Sell |
13,039
-257
| -2% | -$123K | 0.08% | 157 |
|
|
2025
Q1 | $5.58M | Buy |
13,296
+947
| +8% | +$411K | 0.06% | 186 |
|
|
2024
Q4 | $5.11M | Buy |
12,349
+1,274
| +12% | +$559K | 0.06% | 188 |
|
|
2024
Q3 | $5.6M | Buy |
11,075
+134
| +1% | +$65.1K | 0.06% | 191 |
|
|
2024
Q2 | $5.33M | Buy |
10,941
+288
| +3% | +$145K | 0.06% | 189 |
|
|
2024
Q1 | $5.75M | Sell |
10,653
-955
| -8% | -$522K | 0.07% | 197 |
|
|
2023
Q4 | $6.44M | Buy |
11,608
+1,571
| +16% | +$738K | 0.08% | 187 |
|
|
2023
Q3 | $4.39M | Sell |
10,037
-58
| -0.6% | -$28.9K | 0.06% | 216 |
|
|
2023
Q2 | $5.07M | Buy |
10,095
+3
| +0% | +$1.44K | 0.06% | 207 |
|
|
2023
Q1 | $5.05M | Buy |
10,092
+563
| +6% | +$269K | 0.06% | 212 |
|
|
2022
Q4 | $3.89M | Buy |
9,529
+19
| +0.2% | +$7.38K | 0.05% | 242 |
|
|
2022
Q3 | $3.1M | Sell |
9,510
-32
| -0.3% | -$11.8K | 0.04% | 266 |
|
|
2022
Q2 | $3.35M | Buy |
9,542
+252
| +3% | +$103K | 0.04% | 270 |
|
|
2022
Q1 | $5.08M | Sell |
9,290
-5
| -0.1% | -$2.63K | 0.05% | 235 |
|
|
2021
Q4 | $6.12M | Sell |
9,295
-60
| -0.6% | -$37.7K | 0.06% | 216 |
|
|
2021
Q3 | $5.82M | Buy |
9,355
+37
| +0.4% | +$24.9K | 0.06% | 217 |
|
|
2021
Q2 | $5.88M | Sell |
9,318
-89
| -0.9% | -$49.1K | 0.06% | 225 |
|
|
2021
Q1 | $4.6M | Sell |
9,407
-262
| -3% | -$131K | 0.05% | 249 |
|
|
2020
Q4 | $4.83M | Sell |
9,669
-3,052
| -24% | -$1.37M | 0.05% | 246 |
|
|
2020
Q3 | $5M | Sell |
12,721
-1,521
| -11% | -$562K | 0.06% | 221 |
|
|
2020
Q2 | $4.7M | Sell |
14,242
-170
| -1% | -$49.2K | 0.06% | 236 |
|
|
2020
Q1 | $3.49M | Buy |
14,412
+12,611
| +700% | +$3.29M | 0.04% | 252 |
|
|
2019
Q4 | $470K | Sell |
1,801
-163
| -8% | -$43K | ﹤0.01% | 447 |
|
|
2019
Q3 | $534K | Sell |
1,964
-2,498
| -56% | -$695K | 0.01% | 454 |
|
|
2019
Q2 | $1.23M | Sell |
4,462
-100
| -2% | -$24.6K | 0.01% | 423 |
|
|
2019
Q1 | $1.02M | Sell |
4,562
-184
| -4% | -$38K | 0.01% | 453 |
|
|
2018
Q4 | $883K | Sell |
4,746
-215
| -4% | -$44.1K | 0.01% | 474 |
|
|
2018
Q3 | $1.24M | Sell |
4,961
-185
| -4% | -$44.9K | 0.01% | 431 |
|
|
2018
Q2 | $1.12M | Sell |
5,146
-330
| -6% | -$68K | 0.01% | 444 |
|
|
2018
Q1 | $1.05M | Sell |
5,476
-1,580
| -22% | -$292K | 0.01% | 473 |
|
|
2017
Q4 | $1.1M | Sell |
7,056
-799
| -10% | -$126K | 0.01% | 481 |
|
|
2017
Q3 | $1.22M | Sell |
7,855
-121
| -2% | -$19.1K | 0.01% | 470 |
|
|
2017
Q2 | $1.29M | Buy |
7,976
+601
| +8% | +$97.6K | 0.01% | 443 |
|
|
2017
Q1 | $1.14M | Buy |
7,375
+5,328
| +260% | +$734K | 0.01% | 447 |
|
|
2016
Q4 | $240K | Hold |
2,047
| – | – | ﹤0.01% | 637 |
|
|
2016
Q3 | $231K | Buy |
+2,047
| New | +$216K | ﹤0.01% | 634 |
|
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
RP
Gateway Investment Advisers's IDXX Position: Q2 2026 in Review
Gateway Investment Advisers increased its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, buying an estimated $1.16M and bringing the position to 8,920 shares worth $4.7M. The position accounts for 0.05% of the portfolio, ranked #178.
Gateway Investment Advisers first reported a position in IDXX in Q3 2016 and has held it in 40 quarters since. The position peaked at $8.32M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Gateway Investment Advisers held 8,920 shares of Idexx Laboratories worth $4.7M as of Q2 2026.
- Gateway Investment Advisers bought 2,066 Idexx Laboratories shares in Q2 2026, an estimated $1.16M.
- Idexx Laboratories made up 0.05% of Gateway Investment Advisers's portfolio in Q2 2026, its #178 holding.
- Gateway Investment Advisers first reported a position in Idexx Laboratories in Q3 2016 and has held it in 40 quarters since.
- Gateway Investment Advisers's Idexx Laboratories position peaked at $8.32M in Q4 2025.
- 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.